Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM

10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2023

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

Commission File Number:

001-41114

UTA Acquisition Corporation

(Exact Name of Registrant as Specified in its Charter)


Cayman Islands		98-1616250
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

135 5th Avenue, 7 th Floor New York, NY		10010
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (917)

781-1679

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant	UTAAU	The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share	UTAA	The Nasdaq Stock Market LLC
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share	UTAAW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T

(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files. Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule

12b-2

of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2

of the Exchange Act). Yes ☒ No ☐

As of August

, 2023, the registrant had 23,000,000 Class A ordinary shares, $0.0001 par value per share, and 5,750,000 Class B ordinary shares, $0.0001 par value per share, issued and outstanding.

Table of Contents


		Page
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)		ii
	Condensed Balance Sheets		2
	Condensed Statements of Operations		3
	Condensed Statements of Changes in Stockholders’ Deficit and Class A Shares Subject to Possible Redemption		4
	Condensed Statement of Cash Flows		5
	Notes to Unaudited Condensed Financial Statements		6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		14
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		17
Item 4.	Controls and Procedures		17
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings		18
Item 1A.	Risk Factors		18
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		18
Item 3.	Defaults Upon Senior Securities		18
Item 4.	Mine Safety Disclosures		18
Item 5.	Other Information		18
Item 6.	Exhibits		19

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

INDEX TO FINANCIAL STATEMENTS


	Page
Condensed Balance Sheets as of June 30, 2023 (Unaudited) and December 31, 2022		2
Condensed Statements of Operations for the three and six months ended June 30, 2023 and 2022 (Unaudited)		3
Condensed Statement of Changes in Shareholders’ Deficit and Class A Shares Subject to Possible Redemption for the three and six months ended June 30, 2023 and 2022 (Unaudited)		4
Condensed Statement of Cash Flows for the six months ended June 30, 2023 and 2022 (Unaudited)		5
Notes to the Condensed Financial Statements (Unaudited)		6

Table of Contents

UTA Acquisition Corporation

Condensed Balance Sheets


	June 30, 2023 (Unaudited)			December 31, 2022
Assets:
Cash	$	24,603		$	153,968
Restricted cash held in Trust Account		—			869
Prepaid expenses		301,195			549,405
Marketable securities held in Trust Account		243,390,357			237,994,037

Total assets	$	243,716,155		$	238,698,279

Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit
Current liabilities
Accrued expenses	$	228,545		$	90,385
Related Party Payable		180,000			120,000
Working capital loan - related party		835,993			577,992
Deferred underwriters fee		8,050,000			8,050,000

Total liabilities		9,294,538			8,838,377
Commitments and Contingencies (Note 5)
Class A ordinary shares subject to possible redemption, $0.0001 par value, 23,000,000 shares outstanding at redemption value		243,390,356			237,994,906
Shareholders’ Deficit:
Preference shares, $0.0001 par value; 1,000,000 shares authorized, none issued and outstanding		—			—
Class A ordinary shares, $0.0001 par value; 80,000,000 shares authorized; none issued and outstanding, excluding 23,000,000 shares subject to possible redemption		—			—
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding		575			575
Additional paid-in capital		—			—
Accumulated deficit		(8,969,314	)		(8,135,579	)

Total Shareholders’ Deficit		(8,968,739	)		(8,135,004	)

Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit	$	243,716,155		$	238,698,279

The accompanying notes are an integral part of these condensed financial statements

Table of Contents

UTA Acquisition Corporation

Condensed Statements of Operations

(Unaudited)


	For the Three Months Ended June 30,						For the Six Months Ended June 30,
	2023			2022			2023			2022


Formation and operating costs	$	301,124		$	282,455		$	833,735		$	656,827

Loss from operations		(301,124	)		(282,455	)		(833,735	)		(656,827	)
Realized and unrealized gain on marketable securities held in trust		—			123,065			1,440,963			8,280
Interest income on securities held in trust		2,867,725			174,841			3,954,487			233,521

Net income (loss)	$	2,566,601		$	15,451		$	4,561,715		$	(415,026	)

Weighted average shares outstanding of class A ordinary shares subject to possible redemption, basic and diluted		23,000,000			23,000,000			23,000,000			23,000,000

Basic and diluted net income per share, Class A ordinary shares subject to possible redemption	$	0.11		$	0.00		$	0.21		$	(0.01	)

Weighted-average Class B ordinary outstanding, basic and diluted, non-redeemable shares	$	5,750,000		$	5,750,000		$	5,750,000		$	5,750,000

Basic and diluted net loss per share, Class B non-redeemable ordinary shares	$	(0.01	)	$	(0.01	)	$	(0.03	)	$	(0.02	)

The accompanying notes are an integral part of these condensed financial statements

Table of Contents

UTA Acquisition Corporation

Condensed Statements of Changes in Stockholders’ Deficit and Class A Shares Subject to Possible Redemption

(Unaudited)

For the Three and Six Months Ended June 30, 2023


	Class A Ordinary Shares Subject to Possible Redemption				Class B Ordinary Shares				Additional Paid-in Capital		Accumulated Deficit			Shareholders’ Deficit
	Shares		Amount		Shares		Amount		Additional Paid-in Capital		Accumulated Deficit			Shareholders’ Deficit
Balance – December 31, 2022		23,000,000	$	237,994,906		5,750,000	$	575	$	—	$	(8,135,579	)	$	(8,135,004	)

Accretion of Class A ordinary shares to redemption value		—		2,527,725		—		—		—		(2,527,725	)		(2,527,725	)
Net income		—		—		—		—		—		1,995,114			1,995,114

Balance – March 31, 2023		23,000,000	$	240,522,631		5,750,000	$	575	$	—	$	(8,668,190	)	$	(8,667,615	)

Accretion of Class A ordinary sh are s to redemption value		—		2,867,725		—		—		—		(2,867,725	)		(2,867,725	)
Net income		—		—		—		—		—		2,566,601			2,566,601

Balance – June 30, 2023		23,000,000	$	243,390,356		5,750,000	$	575	$	—	$	(8,969,314	)	$	(8,968,739	)

For the Three and Six Months Ended June 30, 2022


	Class A ordinary shares subject to possible redemption					Class B Ordinary Shares				Additional Paid-in Capital		Accumulated Deficit			Shareholders’ Deficit
	Shares		Amount			Shares		Amount		Additional Paid-in Capital		Accumulated Deficit			Shareholders’ Deficit
Balance – December 31, 2021		23,000,000	$	234,606,064			5,750,000	$	575	$	—	$	(6,854,636	)	$	(6,854,061	)
Accretion of Class A ordinary shares to redemption value		—		(56,105	)		—		—		—		56,105			56,105
Net loss		—		—			—		—		—		(430,477	)		(430,477	)

Balance – March 31, 2022		23,000,000	$	234,549,959			5,750,000	$	575	$	—	$	(7,229,008	)	$	(7,228,433	)

Accretion of Class A ordinary shares to redemption value		—		297,906			—		—		—		(297,906	)		(297,906	)
Net income		—		—			—		—		—		15,451			15,451

Balance – June 30, 2022		23,000,000	$	234,847,865			5,750,000	$	575	$	—	$	(7,511,463	)	$	(7,510,888	)

The accompanying notes are an integral part of these condensed financial statements

Table of Contents

UTA Acquisition Corporation

Condensed Statement of Cash Flows

(Unaudited)


	For the Six Months Ended June 30, 2023			For the Six Months Ended June 30, 2022

Cash flows from operating activities:
Net income (loss)	$	4,561,715		$	(415,026	)
Adjustments to reconcile net loss to net cash used in operating activities:
Realized and u nrealized gain on marketable securities held in trust		(1,440,963	)		(241,801	)
Change in accrued interest included in marketable securities held in trust		(1,007,769	)		—
Changes in operating assets and liabilities:
Prepaid expenses		248,210			274,600
Accrued expenses and related party payable		198,160			(30,269	)

Net cash provided by (used in) operating activities		2,559,353			(412,496	)

Cash flows from investing activities:
Proceeds from redemption of marketable securities held in trust account		239,435,000			234,718,663
Investment in marketable securities held in trust account		(242,382,588	)		(234,718,663	)

Net cash used in investing activities		(2,947,588	)		—

Cash flows from financing activities:
Cash proceeds from working capital loan		258,001			—

Net cash provided by financing activities		258,001			—

Net change in cash and restricted cash		(130,234	)		(412,496	)
Cash and restricted cash – beginning of period		154,837			416,437

Cash and restricted cash – end of period	$	24,603		$	3,941

Supplemental disclosure of non-cash investing and financing activities:
Accretion of Class A ordinary shares to redemption value	$	5,395,450		$	(241,801	)

The accompanying notes are an integral part of these condensed financial statements

Table of Contents

UTA Acquisition Corporation

Notes to Condensed Financial Statements (Unaudited)

Note 1—Description of Organization, Business Operations and Basis of Presentation

UTA Acquisition Corporation (the “Company”) was incorporated as a Cayman Island exempted company on July 15, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As further discussed in the Business Combination section, the Company has until September 6, 2023 to complete a Business Combination, at which time it will be obligated to redeem 100% of the public shares if it is unable to do so, as defined and described below. As of June 30, 2023, the Company has not taken any action to extend the business combination period beyond September 6, 2023.

As of June 30, 2023, the Company had not commenced any operations. All activity through June 30, 2023 relates to the Company’s formation, the initial public offering (“IPO”) described below, and identifying a target for an initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates

non-operating

income in the form of interest income from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end.

Sponsor and Financing

The Company’s sponsor is UTA Acquisition Sponsor, LLC (the “Sponsor”). The registration statement for the Company’s IPO was declared effective on December 1, 2021. On December 6, 2021, the Company consummated its IPO of 23,000,000 units (the “Units”), including the issuance of 3,000,000 Units as a result of the underwriter’s exercise of its over-allotment option. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (an “Ordinary Share”, with each such Ordinary Share included in the Units being offered, the “Public Shares”), and

one-half

of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Ordinary Share for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000. Substantially concurrently with the closing of the IPO, the Company completed the private sale of 11,200,000 Private Placement Warrants at a purchase price of $1.00 per Private Placement Warrant, to the Sponsor, generating gross proceeds to the Company of $11,200,000 as discussed in Note 4.

Transaction costs of the IPO amounted to $13,252,780 consisting of $4,600,000 of underwriting discounts and commissions, $8,050,000 of deferred underwriting discounts and commissions, and $602,780 of other offering costs.

Trust Account

2a-7

promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the funds held in the Trust Account will not be released from the Trust Account until the earliest to occur of: (1) the completion of the Company’s initial business combination; (2) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial business combination or to redeem 100% of its public shares if the Company does not complete its initial business combination within 21 months from the closing of the IPO or (B) with respect to any other provision relating to shareholders’ rights or

pre-initial

business combination activity; and (3) the redemption of the Company’s public shares if the Company has not completed its initial business combination within 21 months from the closing of the IPO, subject to applicable law. As of June 30, 2023 and December 31, 2022, marketable securities held in the Trust Account amounted to $243,390,357 and $237,994,037, respectively.

Business Combination

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially all the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes and excluding the amount of any deferred underwriting discount held in trust) at the time of the agreement to enter the initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”).

The Company will provide holders of the Company’s outstanding Class A ordinary shares sold in the IPO (the “Public Shareholders”), the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account. The

per-share

amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares are classified as temporary equity and subsequentially accreted to redemption value in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”

Table of Contents

UTA Acquisition Corporation

Notes to Condensed Financial Statements

The Company will not redeem the Public Shares in an amount that would cause its net tangible assets to be less than $5,000,005. The Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by applicable law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its amended and restated certificate of incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by applicable law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor and the Company’s officers and directors have agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the IPO in favor of a Business Combination. In addition, the Sponsor and the Company’s officers and directors have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.

The Certificate of Incorporation provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.

The Sponsor and the Company’s officers and directors have agreed not to propose an amendment to the Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemptions in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other material provision relating to shares’ rights or

pre-business

combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

If the Company is unable to complete a Business Combination within 21 months from the closing of the IPO (the “Combination Period”), September 6, 2023, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than

ten

business days thereafter, redeem the Public Shares, at a

per-share

price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less amounts released to pay taxes and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, liquidate and dissolve, subject in each case, to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

The holders of the Company’s Founder Shares prior to the IPO (the “initial shareholders”) have agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders or the Company’s officers and directors acquire Public Shares in or after the IPO, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.20.

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective targets or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Liquidity, Capital Resources and Going Concern

As of June 3

, 2023, the Company had $24,603 in cash and working capital deficiency of

918,740. The working capital calculation excludes amounts held in the Trust Account from current assets and excludes deferred underwriters’ fees from current liabilities. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor agreed to loan the Company an aggregate of up to $2,500,000 funds as may be required (“Working Capital Loans”). As of June 30, 2023, the Company had $835,993 in outstanding borrowings under such Working Capital Loans.

The Company uses funds held outside of the Trust Account and borrowings under the Working Capital Loans to pay existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating a Business Combination. The Company believes that the funds available may not be sufficient to meet the expenditures required for operating our business through a period of one year from the date of these condensed financial statements.

Table of Contents

UTA Acquisition Corporation

Notes to Condensed Financial Statements

We may need to obtain additional financing either to complete an initial business combination or because we become obligated to redeem a significant number of our Public Shares upon completion of an initial business combination, in which case we may issue additional securities or incur debt in connection with such business combination. There is no assurance that management would be able to secure these additional funds.

As a result, the Company’s management has determined that the current liquidity conditions raise substantial doubt about our ability to continue as a going concern.

Note 2—Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited

interim

condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The summary of significant accounting policies presented below is designed to assist in understanding the Company’s condensed financial statements. Such condensed financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity. As of June 30, 2023, all assets and liabilities are classified as current, as the Combination Period is within 12 months of the reporting date.

The accompanying unaudited interim condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed by the Company with the SEC.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), which exempts emerging growth companies from compliance with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to

non-emerging

growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company’s condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities during the reporting period and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

We consider all highly liquid investments with an original maturity of three months or less to be “cash equivalents.” The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022.

Restricted Cash Held in Trust Account

Restricted cash represents cash that is not readily available for general operating needs. The balance consists of cash held in the Trust Account yet to be reinvested. As of June 30, 2023 and December 31, 2022, cash held in the Trust Account classified as restricted cash on the balance sheet amounted to $0 and $869, respectively.

Marketable Securities Held in Trust Account

As of June 30, 2023 and December 31, 2022, the Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities and U.S. Treasuries, respectively, with a maturity of 185 days or less. Marketable securities held in the Trust Account are classified as trading securities and presented on the balance sheet at fair value at the end of the period. Gains and losses resulting from the change in fair value of these investments are included in realized and unrealized gain (loss) on marketable securities held in trust in the accompanying condensed statement of operations.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of its cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. The Company holds regular communications with financial institutions to discuss current market exposures to assess the financial strength and credit worthiness of parties to which it extends funds and as such, it believes that any associated credit risk exposures are limited. As of June 30, 2023 and December 31, 2022, the Company has not experienced losses on its account and management believes the Company is not exposed to significant risks on such account.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and is measured at fair value. Conditionally redeemable Class A ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2023 and December 31, 2022, 23,000,000 Class A ordinary shares subject to possible redemption are presented, at redemption value, as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheet.

Table of Contents

UTA Acquisition Corporation

Notes to Condensed Financial Statements

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Such changes are reflected in additional

paid-in

capital, or in the absence of additional capital, in accumulated deficit. For the three and six months ended June 30, 2023, the Company recorded an-upward accretion to redemption value of $

2,867,725

and $5,395,450

, respectively, all of which was recorded in accumulated deficit. For the three and six months ended June 30, 2022, the Company recorded accretion to redemption value of $297,906 and $241,801, respectively, all of which was recorded in

accumulated

deficit.

Offering Costs

Offering costs consist of legal, accounting, and other costs incurred that are directly related to the IPO and were charged against the carrying values of Class A ordinary shares and the warrants sold in the Units, based on their respective relative fair values. Accordingly, upon consummation of the IPO on December 6, 2021, offering costs in the aggregate of $13,252,780 were recognized, of which $12,723,198 and $529,582 was allocated to Class A ordinary shares and the public warrants, respectively. During the three and six months ended

June 30, 2023 and 2022,

no offering costs were incurred or recorded.

Net Income (Loss) Per Ordinary Share

The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average ordinary shares outstanding for the respective period. Net loss for the period from inception to IPO was allocated fully to Class B ordinary shares. Diluted net loss per share attributable to ordinary stockholders adjusts the basic net loss per share attributable to ordinary shareholders and the weighted-average ordinary shares outstanding for the potentially dilutive impact of outstanding warrants. However, because the warrants are anti-dilutive, diluted loss per ordinary share is the same as basic loss per ordinary share for the periods presented.

With respect to the accretion of Class A ordinary shares subject to possible redemption and consistent with ASC Topic

480-10-S99-3A,

the Company treated accretion in the same manner as a dividend, paid to the shareholder in the calculation of the net income loss per ordinary share.

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):


	For the Three Months Ended June 30,						For the Six Months Ended June 30,
	2023			2022			2023			2022


Net income (loss)	$	2,566,601		$	15,451		$	4,561,715		$	(415,026	)
Accretion of temporary equity to redemption value		(2,867,725	)		(297,906	)		(5,395,450	)		(241,801	)

Net loss including accretion of temporary equity to redemption value		(301,124	)		(282,455	)		(833,735	)		(656,827	)


	For the Three Months Ended June 30, 2023						For the Six Months Ended June 30, 2023
	Class A			Class B			Class A			Class B
Numerator:
Total income (loss) allocated by Class		2,053,281			513,320			3,649,372			912,343
Less: Accretion allocated based on ownership percentage		(2,294,180	)		(573,545	)		(4,316,360	)		(1,079,090	)
Plus: accretion applicable to Class A redeemable Shares		2,867,725						5,395,450

Total income (loss) by Class	$	2,626,826		$	(60,225	)		4,728,462		$	(166,747	)


Denominator :
Weighted average shares		23,000,000			5,750,000			23,000,000			5,750,000
Basic and diluted net income (loss) per ordinary share		0.11			(0.01	)		0.21			(0.03	)


	For the Three Months Ended June 30, 2022						For the Six Months Ended June 30, 2022
	Class A			Class B			Class A			Class B
Numerator:
Total income (loss) allocated by Class		12,361			3,090			(332,021	)		(83,005	)
Less: Accretion allocated based on ownership percentage		(238,325	)		(59,581	)		(193,441	)		(48,360	)
Plus: accretion applicable to Class A redeemable Shares		297,906			—			241,801			—

Total income (loss) by Class	$	71,942		$	(56,491	)		(283,661	)	$	(131,365	)

Denominator :
Weighted average shares		23,000,000			5,750,000			23,000,000			5,750,000
Basic and diluted net income (loss) per ordinary share		0.00			(0.01	)		(0.01	)		(0.02	)

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the condensed financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the condensed financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2023 and December 31, 2022. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Table of Contents

UTA Acquisition Corporation

Notes to Condensed Financial Statements

The Company is considered to be an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Fair Value Measurement

ASC 820 establishes a fair value hierarchy that prioritizes and ranks the level of observability of inputs used to measure investments at fair value.

The observability of inputs is impacted by a number of factors, including the type of investment, characteristics specific to the investment, market conditions and other factors. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Investments with readily available quoted prices or for which fair value can be measured from quoted prices in active markets will typically have a higher degree of input observability and a lesser degree of judgment applied in determining fair value.

The three levels of the fair value hierarchy under ASC 820 are as follows:

Level 1—Quoted prices (unadjusted) in active markets for identical investments at the measurement date are used.

Level 2—Pricing inputs are other than quoted prices included within Level 1 that are observable for the investment, either directly or indirectly. Level 2 pricing inputs include quoted prices for similar investments in active markets, quoted prices for identical or similar investments in markets that are not active, inputs other than quoted prices that are observable for the investment, and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Level 3—Pricing inputs are unobservable and include situations where there is little, if any, market activity for the investment. The inputs used in determination of fair value require significant judgment and estimation.

In some cases, the inputs used to measure fair value might fall within different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the investment is categorized in its entirety is determined based on the lowest level input that is significant to the investment. Assessing the significance of a particular input to the valuation of an investment in its entirety requires judgment and considers factors specific to the investment. The categorization of an investment within the hierarchy is based upon the pricing transparency of the investment and does not necessarily correspond to the perceived risk of that investment.

As of June 30, 2023 and December 31, 2022, the Company’s assets measured at fair value on a recurring basis consist of U.S. government securities and U.S. Treasuries, respectively, held in Trust classified within Level 1 of the fair value hierarchy. The Company determined the fair value of its Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments.

Recent Accounting Pronouncements

The Company’s management does not believe that any recently issued accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements.

Note 3—Initial Public Offering

As discussed in Note 1, on December 6, 2021, the Company consummated its IPO of 23,000,000 Units, including the issuance of 3,000,000 Units as a result of the underwriter’s exercise of its over-allotment option. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000.

Note 4—Related Party Transactions

Founder Shares

On July 22, 2021, the Sponsor paid an aggregate price of $25,000 to cover certain expenses on behalf of the Company in exchange for an initial issuance of 7,187,500 shares of Class B ordinary shares (the “Founder Shares”). In November 2021, the Sponsor surrendered an aggregate of 1,437,500 Founder Shares for no consideration, resulting in an aggregate of 5,750,000 Class B ordinary shares outstanding. All share and per share amounts have been retroactively restated to reflect the share surrender.

In November 2021, the Sponsor transferred 25,000 Founder Shares each to Nancy Tellem and Alexis Ohanian, the Company’s independent director nominees.

The initial shareholders, including the Sponsor, have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (i) one year after the completion of the initial Business Combination and (ii) subsequent to our initial business combination (x) if the last reported sale price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share

sub-divisions,

share dividends, rights issuances, consolidations, reorganizations, recapitalizations and other similar transactions) for any

trading days within any

-trading

day period commencing at least 150 days after our initial business combination or (y) the date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property.

Table of Contents

UTA Acquisition Corporation

Notes to Condensed Financial Statements

Private Placement Warrants

Substantially concurrently with the closing of the IPO, the Company completed the private sale of 11,200,000 Private Placement Warrants at a purchase price of $1.00 per Private Placement Warrant, to the Sponsor, generating gross proceeds to the Company of $11,200,000. Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be

non-redeemable

for cash and exercisable for cash or on a cashless basis so long as they are held by the Sponsor or its permitted transferees.

The Sponsor and the Company’s officers and directors have agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.

The Private Placement Warrants are identical to the warrants sold as part of the Units in the IPO except that, so long as they are held by the Sponsor or its permitted transferees: (1) they will not be redeemable by the Company (except in certain redemption scenarios when the price per Class A ordinary share equals or exceeds $10.00 (as adjusted)); (2) they (including the Class A ordinary shares issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the Company’s initial business combination; (3) they may be exercised by the holders on a cashless basis; and (4) they (including the Ordinary Shares issuable upon exercise of these warrants) are entitled to registration rights.

Working Capital Loans—Related Party

In order to finance transaction costs in connection with a Business Combination, the Sponsor agreed to loan the Company an aggregate of up to $2,500,000 funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans are

non-interest

bearing and due at the earlier of (i) September 6, 2023, (ii) the date of consummation of a Business Combination or, (iii) pursuant to acceleration of the obligations upon an event of default. At the lender’s discretion, up to $2,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. The embedded feature to settle the Working Capital Loans upon the occurrence of an event of default is clearly and closely related to the debt host and is therefore not required to be separated. As of June 30, 2023 and December 31, 2022, the Company had $835,993

and $577,992, respectively, in outstanding borrowings under the Working Capital Loans.

Administrative Services Agreement

On December 1, 2021, the Company entered into an agreement that provides that, commencing on the closing of the IPO and continuing until the earlier of the Company’s consummation of a Business Combination or the Company’s liquidation, the Company will pay an affiliate of the Sponsor a total of $10,000 per month for office space, secretarial and administrative services. The Sponsor subsequently agreed to waive any fees that would have been payable by the Company under the agreement for the month of December 2021. For the three and six months ended June 30,

2023 and

2022, $30,000 and $60,000 respectively, was incurred and recognized in formation and operating costs in the condensed statement of operations. As of June 30, 2023 and December 31, 2022, $

180,000

and $120,000, respectively, was payable and included in payable to affiliate on the condensed balance sheet.

The Sponsor, executive officers and directors, or any of their respective affiliates, will be reimbursed for any

out-of-pocket

expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made to the Sponsor, officers, directors or their affiliates. No such expenditures were incurred for the three and six months ended June 30, 2023 and 2022.

Note 5—Commitments and Contingencies

Registration Rights

The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement signed upon consummation of the IPO. These holders are entitled to certain demand and “piggyback” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Risks and Uncertainties

Management continues to evaluate the impact of the Russia-Ukraine war on the industry and has concluded that while it is reasonably possible that such could have negative effects on the Company’s financial position, results of its operations, and/or search for a target company, the specific impacts are not readily determinable as of the date of these condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Underwriting Agreement

The underwriters were entitled to an underwriting discount of $0.20 per unit, or $4,600,000 in the aggregate paid upon the closing of the IPO. Additionally, the underwriters are entitled to a deferred underwriting discount of $0.35 per unit, or $8,050,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Table of Contents

UTA Acquisition Corporation

Notes to Condensed Financial Statements

Note 6—Class A Ordinary Shares Subject to Possible Redemption

The Company is authorized to issue 80,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were 23,000,000 shares of Class A ordinary shares outstanding, all of which were subject to redemption. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events.

As of June 30, 2023, Class A ordinary shares reflected on the balance sheet is reconciled as follows:



Class A ordinary shares subject to possible redemption - December 31, 2022	$	237,994,906
Plus:
Accretion of carrying value to redemption value		5,395,450

Class A ordinary shares subject to possible redemption - June 30, 2023	$	243,390,356

As of June 30, 2022, Class A ordinary shares reflected on the balance sheet is reconciled as follows:



Class A ordinary shares subject to possible redemption - December 31, 2021	$	234,606,064
Plus:
Accretion of carrying value to redemption value		241,801

Class A ordinary shares subject to possible redemption - June 30, 2022	$	234,847,865

Note 7—Shareholder’s Equity

Preference Shares —

The Company is authorized to issue 1,000,000 preference shares, par value $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2023 and December 31, 2022, there were no preference shares issued and outstanding.

Class

A Ordinary Shares

—The Company is authorized to issue 80,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of June 30, 2023, and December 31, 2022, there were 23,000,000 Class A ordinary shares issued and outstanding, all subject to possible redemption and classified as temporary equity in the accompanying balance sheet (see Note 6).

Class

B Ordinary Shares

—The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. On July 22, 2021, the Sponsor paid an aggregate price of $25,000 to cover certain expenses on behalf of the Company in exchange for the issuance of 5,750,000 Class B ordinary shares outstanding.

Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s stockholders except as required by law.

The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination, or earlier at the option of the holder, on a

one-for-one

basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of shares of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an

as-converted

basis, 20% of the total number of shares of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of shares of Class A ordinary shares by Public Stockholders), including the total number of shares of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any shares of Class A ordinary shares or equity-linked securities or rights exercisable for or convertible into shares of Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans, provided that such conversion of Founder Shares will never occur on a less than

one-for-one

basis.

Warrants

— As of June 30, 2023 and December 31, 2022, the Company had 11,500,000 and 11,200,000 Public Warrants and Private Placement Warrants outstanding, respectively.

The Company accounts for both the Public and Private Warrants

in accordance with the guidance contained in ASC

815-40.

Such guidance provides that because the warrants meet the criteria for equity treatment thereunder, each warrant must be recorded within equity.

Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the IPO. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

Once the warrants become exercisable, the Company may redeem the Public Warrants:

•

in whole and not in part;

•

at a price of $0.01 per warrant;

•

at any time after the warrants become exercisable;

•

upon a not less than 30 days’ prior written notice of redemption;

•

if, and only if, the last sales price of the Class A ordinary shares for any 20 days within a

30-trading

day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders equals or exceeds $18.00 per share.

•

if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire

30-day

trading period referred to above and continuing each day thereafter until the date of redemption, or the Company has elected to require the exercise of the Public Warrants on a cashless basis.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger, or consolidation. Additionally, in no event will the Company be required to net cash settle the warrants.

Table of Contents

UTA Acquisition Corporation

Notes to Condensed Financial Statements

If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

If the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Class B Ordinary Shares, par value $0.0001 per share, of the Company held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 10 trading day period starting on the trading day after the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price.

The Private Placement Warrants are identical to the warrants sold as part of the Units in the IPO except that, so long as they are held by the Sponsor or its permitted transferees: (1) they will not be redeemable by the Company (except in certain redemption scenarios when the price per Ordinary Share equals or exceeds $10.00 (as adjusted)); (2) they (including the Ordinary Shares issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the Company’s initial business combination; (3) they may be exercised by the holders on a cashless basis; and (4) they (including the Ordinary Shares issuable upon exercise of these warrants) are entitled to registration rights.

Note 8—Subsequent Events

The Company has evaluated subsequent events and transactions that occurred after the balance sheet date through the date these financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to UTA Acquisition Corporation. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to UTA Acquisition Sponsor, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public Offering (as defined below) filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s filings with the SEC can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company, incorporated as a Cayman Islands exempted company on July 15, 2021 for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We intend to effectuate our initial business combination using cash from the proceeds of our initial public offering and the sale of the private placement warrants, our shares, debt or a combination of cash, shares and debt.

On December 6, 2021, we consummated our initial public offering (the “IPO”) of 23,000,000 units (the “Units”), including the issuance of 3,000,000 Units as a result of the underwriter’s exercise of its over-allotment option. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (an “Ordinary Share”), and one-half of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Ordinary Share for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000.

Substantially concurrently with the closing of the IPO, we completed the private sale of 11,200,000 Private Placement Warrants at a purchase price of $1.00 per Private Placement Warrant, to the sponsor, generating gross proceeds of $11,200,000.

A total of $234,600,000, comprised of proceeds from the IPO and the sale of the Private Placement Warrants, was placed in the Trust Account, a U.S.-based trust account at JP Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the funds held in the Trust Account will not be released from the Trust Account until the earliest to occur of: (1) the completion of the Company’s initial business combination; (2) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial business combination or to redeem 100% of its public shares if the Company does not complete its initial business combination within 21 months from the closing of the IPO or (B) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity; and (3) the redemption of the Company’s public shares if the Company has not completed its initial business combination within 21 months from the closing of the IPO, subject to applicable law.

Business Combination

If we are unable to complete a business combination within 21 months from the closing of the initial public offering (the “combination period”), we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (less amounts released to pay taxes and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

The issuance of additional ordinary shares or preference shares in connection with an initial business combination:

•

may significantly dilute the equity interest of investors in our initial public offering, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares;

•

may subordinate the rights of holders of ordinary shares if preference shares are issued with rights senior to those afforded our ordinary shares;

•

could cause a change in control if a substantial number of ordinary shares is issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;

•

may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us;

•

may adversely affect prevailing market prices for our units, ordinary shares and/or warrants; and

•

may not result in adjustment to the exercise price of our warrants.

Similarly, if we issue debt securities or otherwise incur significant debt, it could result in:

•

default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;

•

acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;

•

our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;

•

our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding;

•

using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our ordinary shares if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general corporate purposes;

•

limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;

•

increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and

•

limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution of our strategy.

We expect to continue to incur significant costs in the pursuit of our initial business combination plans. We cannot assure you that our plans to raise capital or to complete our initial business combination will be successful.

Results of Operations

We have neither engaged in any operations nor generated any operating revenues to date. Our only activities for the three and six months ended June 30, 2023 were identifying a target company for a business combination. We do not expect to generate any operating revenues until after the completion of our initial business combination. We will generate non-operating income in the form of interest income on cash and cash equivalents held after the Initial Public Offering. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the three months ended June 30, 2023, we had net income of $2,566,601, which resulted entirely from earnings on investments held in Trust Account of 2,867,725, offset by formation and operating costs of $301,124.

For the six months ended June 30, 2023, we had net income of $4,561,715, which resulted entirely from earnings on investments held in Trust Account of $5,395,450, offset by formation and operating costs of $833,735.

For the three months ended June 30, 2022, we had net income of $15,451, which resulted entirely from earnings on investments held in Trust Account of $297,906, offset by formation and operating costs of $282,455.

For the six months ended June 30, 2022, we had a net loss of $415,026, which resulted entirely from formation and operating costs of $656,827, offset by earnings on investments held in Trust Account of $241,801.

Liquidity and Capital Resources

Our liquidity needs prior to the completion of our IPO had been satisfied through receipt of $25,000 from the sale of the founder shares to our sponsor and loans from our sponsor under an unsecured promissory note.

On December 6, 2021, we consummated our IPO of 23,000,000 Units including the issuance of 3,000,000 Units as a result of the underwriter’s exercise of its over-allotment option. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000.

The net proceeds from (1) the sale of the units in our initial public offering, after deducting offering expenses of $602,780 and underwriting commissions of $4,600,000, since the underwriter’s over-allotment option was exercised in full, and (2) the sale of the private placement warrants for a purchase price of $11,200,000 in the aggregate were $235,997,220 in the aggregate. Of this amount, $234,600,000, including $8,050,000 in deferred underwriting commissions, was deposited into Trust Account. The funds in the Trust Account are invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (which interest shall be net of taxes payable and excluding deferred underwriting commissions) to complete our initial business combination. We may withdraw interest to pay taxes, if any. Our annual income tax obligations will depend on the amount of interest and other income earned on the amounts held in the Trust Account. We expect the interest earned on the amount in the Trust Account will be sufficient to pay our taxes. We expect the only taxes payable by us out of the funds in the Trust Account will be income and franchise taxes, if any. To the extent that our ordinary shares or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

As of June 30, 2023, we had cash outside our Trust Account of $24,603 and had a working capital deficiency of $918,740. In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor agreed to loan us funds of up to $2,500,000 as may be required (the “Working Capital Loans”), of which $1,664,007 remains available as of June 30, 2023. If we complete our initial business combination, we may repay such Working Capital Loans out of the proceeds of the trust account released to us. Otherwise, such Working Capital Loans may be repaid only out of funds held outside the trust account. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used to repay such loaned amounts. Up to $2,500,000 of the Working Capital Loans may be convertible into warrants at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the private placement warrants issued to our sponsor. We do not expect to seek loans from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.

In addition, we could use a portion of the funds not being placed in trust to pay commitment fees for financing, fees to consultants to assist us with our search for a target business or as a down payment or to fund a “no-shop” provision (a provision designed to keep target businesses from “shopping” around for transactions with other companies or investors on terms more favorable to such target businesses) with respect to a particular proposed business combination, although we do not have any current intention to do so. If we entered into an agreement where we paid for the right to receive exclusivity from a target business, the amount that would be used as a down payment or to fund a “no-shop” provision would be determined based on the terms of the specific business combination and the amount of our available funds at the time. Our forfeiture of such funds (whether as a result of our breach or otherwise) could result in our not having sufficient funds to continue searching for, or conducting due diligence with respect to, prospective target businesses.

Contractual Obligations

Related Party Loans

In addition, in order to finance transaction costs in connection with a Business Combination, the sponsor agreed to loan us funds as may be required (“Working Capital Loans”), up to $2,500,000. If we complete a Business Combination, we will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans are due at the earlier of September 6, 2023 and the date of consummation of a Business Combination or, at the lender’s discretion, up to $2,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of June 30, 2023, we had borrowings of $835,993 under the Working Capital Loans.

Registration Rights

The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, (and any shares of Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement entered into on December 1, 2021. These holders will be entitled to certain demand and “piggyback” registration rights. We will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

Upon closing of the IPO, we paid $4,600,000 to the underwriters for underwriting discounts and commissions. Additionally, the underwriters are entitled to a deferred underwriting discount of $8,050,000 which will be payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.

Critical Accounting Estimates

The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. There were no critical accounting estimates. We have identified the following critical accounting policies:

Net Income (Loss) Per Ordinary Share

See Note 2, Summary of Significant Accounting Policies, for the Company’s accounting and disclosures of ASC Topic 260, “Earnings Per Share.”

Recent Accounting Standards

The Company’s management does not believe that any recently issued accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements.

JOBS Act

The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for nonemerging growth companies. As a result, the condensed financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the condensed financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2023. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended June 30, 2023 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are not currently subject to any material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened against us or any of our officers or directors in their corporate capacity.

ITEM 1A. RISK FACTORS

As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed with the SEC on March 31, 2023, except as described below. Any of those risk factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

Nasdaq has delisted our public warrants and may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions.

We cannot assure you that our securities will continue to be listed on Nasdaq. In order to continue listing our securities on Nasdaq prior to our initial Business Combination, we must maintain certain financial, distribution and share price levels. In general, we must maintain a minimum amount in shareholders’ equity and a minimum of 300 round lot holders for our ordinary shares. On June 24, 2023, we received a written notice from the Listing Qualifications Department of Nasdaq indicating that we are not in compliance with Listing Rule 5452(b)(B), which requires the public warrants to be held by at least 100 holders in order to continue the listing of the public warrants on the Nasdaq Global Market. Accordingly, the Company’s warrants were suspended from the Nasdaq Global Market on August 2, 2023, and a Form 25-NSE was filed with the Securities and Exchange Commission (the “SEC”), which removed the Company’s warrants from listing and registration on Nasdaq.

If any of our securities are delisted from trading on its exchange and we are not able to list our securities on another national securities exchange, we expect such securities could be quoted on an over-the-counter market. If this were to occur, we could face significant material adverse consequences, including:

•

a limited availability of market quotations for our securities;

•

reduced liquidity for our securities;

•

a determination that our Class A ordinary shares are a “penny stock” which will require brokers trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities;

•

a limited amount of news and analyst coverage; and

•

a decreased ability to issue additional securities or obtain additional financing in the future.

The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or pre-empts the states from regulating the sale of certain securities, which are referred to as “covered securities.” Our Units, Class A ordinary shares and warrants currently qualify as covered securities under such statute. Although the states are pre-empted from regulating the sale of covered securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. While we are not aware of a state having used these powers to prohibit or restrict the sale of securities issued by blank check companies, other than the State of Idaho, certain state securities regulators view blank check companies unfavorably and might use these powers, or threaten to use these powers, to hinder the sale of securities of blank check companies in their states. Further, if we were no longer listed on Nasdaq, our securities would not qualify as covered securities under such statute and we would be subject to regulation in each state in which we offer our securities, including in connection with our initial Business Combination, which may negatively impact our ability to consummate our initial Business Combination.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On December 6, 2021, the Company consummated its initial public offering of 23,000,000 units at $10.00 per unit, generating gross proceeds of $230,000,000. Credit Suisse Securities (USA) LLC acted as the sole book-running manager and underwriter of the offering. The securities sold in the initial public offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333-260967). The SEC declared the registration statement effective on December 1, 2021.

Our sponsor purchased 11,200,000 private placement warrants, each exercisable to purchase one ordinary share at $11.50 per share, at a price of $1.00 per warrant ($11,200,000 in the aggregate), in a private placement that closed substantially concurrently with the closing of our initial public offering.

In connection with the initial public offering, we incurred offering costs of approximately $13,252,780 (including deferred underwriting commissions of approximately $8,050,000). Other incurred offering costs consisted principally of preparation fees related to the initial public offering. After deducting the underwriting discounts and commissions (excluding the deferred portion, which amount will be payable upon consummation of the initial business combination, if consummated) and the initial public offering expenses, $234,600,000, of the net proceeds from our initial public offering and certain of the proceeds from the private placement of the private placement warrants (or $10.00 per unit sold in the initial public offering) was placed in the trust account.

There has been no material change in the planned use of the proceeds from the initial public offering and private placement as is described in the Company’s final prospectus related to the initial public offering. For a description of the use of the proceeds generated from the initial public offering, see Part I, Item 2 of this Form 10-Q.

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

(a). None.

(b). None.

(c). During the three months ended June 30, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each such term is defined in Item 408(a) of Regulation S-K.

Item 6. Exhibits.

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.


Exhibit Number		Description

31.1*		Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*		Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1**		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

101.SCH		Inline XBRL Taxonomy Extension Schema Document

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104*		Cover Page Interactive Data File (embedded within the Inline XBRL document)

*	Filed herewith.

**	Furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Clinton Foy, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of UTA Acquisition Corporation;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Chris Jefferis, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of UTA Acquisition Corporation;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(a)

(b)

(c)

(d)

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of UTA Acquisition Corporation (the “Company”) on Form 10-Q for the period ending June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


Date: August 21, 2023	By:	/s/ Clinton Foy
		Clinton Foy
		Co-Chief Executive Officer

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


Date: August 21, 2023	By:	/s/ Chris Jefferis
		Chris Jefferis
		Chief Financial Officer

Cover Page - shares	6 Months Ended
Cover Page - shares	Jun. 30, 2023	Aug. 21, 2023
Document Information Line Items
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Entity Registrant Name	UTA Acquisition Corporation
Entity Central Index Key	0001879221
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity File Number	001-41114
Entity Incorporation State Country Code	E9
Entity Tax Identification Number	98-1616250
Entity Address Address Line1	135 5th Avenue
Entity Address Address Line2	7th Floor
Entity Address City Or Town	New York
Entity Address State Or Province	NY
Entity Address Postal Zip Code	10010
City Area Code	917
Local Phone Number	781-1679
Document Quarterly Report	true
Document Transition Report	false
Units
Document Information Line Items
Security12b Title	Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
Trading Symbol	UTAAU
Security Exchange Name	NASDAQ
Class A Ordinary Shares
Document Information Line Items
Security12b Title	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	UTAA
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		23,000,000
Redeemable Warrants
Document Information Line Items
Security12b Title	Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
Trading Symbol	UTAAW
Security Exchange Name	NASDAQ
Class B Ordinary Shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		5,750,000

Condensed Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Assets:
Cash	$ 24,603	$ 153,968
Restricted cash held in Trust Account	0	869
Prepaid expenses	301,195	549,405
Marketable securities held in Trust Account	243,390,357	237,994,037
Total assets	243,716,155	238,698,279
Current liabilities
Accrued expenses	228,545	90,385
Related Party Payable	180,000	120,000
Working capital loan - related party	835,993	577,992
Deferred underwriters fee	8,050,000	8,050,000
Total liabilities	9,294,538	8,838,377
Commitments and Contingencies (Note 5)
Shareholders' Deficit:
Preference shares, $0.0001 par value; 1,000,000 shares authorized, none issued and outstanding	0	0
Additional paid-in capital	0	0
Accumulated deficit	(8,969,314)	(8,135,579)
Total Shareholders' Deficit	(8,968,739)	(8,135,004)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit	243,716,155	238,698,279
Class A Ordinary Shares Subject to Possible Redemption
Current liabilities
Class A ordinary shares subject to possible redemption, $0.0001 par value, 23,000,000 shares outstanding at redemption value	243,390,356	237,994,906
Class A Ordinary Shares
Shareholders' Deficit:
Ordinary shares	0	0
Class B Ordinary Shares
Shareholders' Deficit:
Ordinary shares	$ 575	$ 575

Condensed Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A Ordinary Shares Subject to Possible Redemption
Class A ordinary shares subject to possible redemption at redemption value per share	$ 0.0001	$ 0.0001
Class A ordinary shares subject to possible redemption at redemption shares outstanding	23,000,000	23,000,000
Temporary equity, shares issued	23,000,000	23,000,000
Class A Ordinary Shares
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	80,000,000	80,000,000
Common stock, shares issued	0	0
Common stock, shares outstanding	0	0
Class B Ordinary Shares
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	5,750,000	5,750,000
Common stock, shares outstanding	5,750,000	5,750,000

Condensed Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
Condensed Statements of Operations - USD ($)	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Formation and operating costs	$ 301,124	$ 282,455	$ 833,735	$ 656,827
Loss from operations	(301,124)	(282,455)	(833,735)	(656,827)
Realized and unrealized gain (loss) on marketable securities held in trust	0	123,065	1,440,963	8,280
Interest income on securities held in trust	2,867,725	174,841	3,954,487	233,521
Net income (loss)	2,566,601	15,451	4,561,715	(415,026)
Class A Ordinary Shares Subject to Possible Redemption
Net income (loss)	$ 2,053,281	$ 12,361	$ 3,649,372	$ (332,021)
Weighted average shares outstanding of class A and B ordinary shares subject to possible redemption, basic	23,000,000	23,000,000	23,000,000	23,000,000
Weighted average shares outstanding of class A and B ordinary shares subject to possible redemption, diluted	23,000,000	23,000,000	23,000,000	23,000,000
Basic net income (loss) per share, Class A and B ordinary shares subject to possible redemption	$ 0.11	$ 0	$ 0.21	$ (0.01)
Diluted net income (loss) per share, Class A and B ordinary shares subject to possible redemption	$ 0.11	$ 0	$ 0.21	$ (0.01)
Class B Ordinary Shares
Net income (loss)	$ 513,320	$ 3,090	$ 912,343	$ (83,005)
Weighted average shares outstanding of class A and B ordinary shares subject to possible redemption, basic	5,750,000	5,750,000	5,750,000	5,750,000
Weighted average shares outstanding of class A and B ordinary shares subject to possible redemption, diluted	5,750,000	5,750,000	5,750,000	5,750,000
Basic net income (loss) per share, Class A and B ordinary shares subject to possible redemption	$ (0.01)	$ (0.01)	$ (0.03)	$ (0.02)
Diluted net income (loss) per share, Class A and B ordinary shares subject to possible redemption	$ (0.01)	$ (0.01)	$ (0.03)	$ (0.02)

Condensed Statements of Changes in Stockholders' Deficit - USD ($)	Total	Class A Ordinary Shares Subject to Possible Redemption	Class B Ordinary Shares	Common Stock Class B Ordinary Shares	Accumulated Deficit
Balance at Dec. 31, 2021		$ 234,606,064
Balance, Shares at Dec. 31, 2021		23,000,000
Balance at Dec. 31, 2021	$ (6,854,061)			$ 575	$ (6,854,636)
Balance, Shares at Mar. 31, 2022				5,750,000
Accretion of Class A ordinary shares to redemption value	56,105	$ (56,105)			56,105
Net income (loss)	(430,477)				(430,477)
Balance at Mar. 31, 2022		$ 234,549,959
Balance, Shares at Mar. 31, 2022		23,000,000
Balance, Shares at Dec. 31, 2021				5,750,000
Balance at Mar. 31, 2022	(7,228,433)			$ 575	(7,229,008)
Balance at Dec. 31, 2021		$ 234,606,064
Balance, Shares at Dec. 31, 2021		23,000,000
Balance at Dec. 31, 2021	(6,854,061)			$ 575	(6,854,636)
Net income (loss)	(415,026)	$ (332,021)	$ (83,005)
Balance at Jun. 30, 2022		$ 234,847,865
Balance, Shares at Jun. 30, 2022		23,000,000
Balance, Shares at Dec. 31, 2021				5,750,000
Balance at Jun. 30, 2022	(7,510,888)			$ 575	(7,511,463)
Balance at Mar. 31, 2022		$ 234,549,959
Balance, Shares at Mar. 31, 2022		23,000,000
Balance at Mar. 31, 2022	(7,228,433)			$ 575	(7,229,008)
Accretion of Class A ordinary shares to redemption value	(297,906)	$ 297,906			(297,906)
Net income (loss)	15,451	12,361	3,090		15,451
Balance at Jun. 30, 2022		$ 234,847,865
Balance, Shares at Jun. 30, 2022		23,000,000
Balance, Shares at Mar. 31, 2022				5,750,000
Balance at Jun. 30, 2022	(7,510,888)			$ 575	(7,511,463)
Balance at Dec. 31, 2022		$ 237,994,906
Balance, Shares at Dec. 31, 2022		23,000,000
Balance at Dec. 31, 2022	(8,135,004)			$ 575	(8,135,579)
Balance, Shares at Mar. 31, 2023				5,750,000
Accretion of Class A ordinary shares to redemption value	(2,527,725)	$ 2,527,725			(2,527,725)
Net income (loss)	1,995,114				1,995,114
Balance at Mar. 31, 2023		$ 240,522,631
Balance, Shares at Mar. 31, 2023		23,000,000
Balance, Shares at Dec. 31, 2022				5,750,000
Balance at Mar. 31, 2023	(8,667,615)			$ 575	(8,668,190)
Balance at Dec. 31, 2022		$ 237,994,906
Balance, Shares at Dec. 31, 2022		23,000,000
Balance at Dec. 31, 2022	(8,135,004)			$ 575	(8,135,579)
Net income (loss)	4,561,715	$ 3,649,372	912,343
Balance at Jun. 30, 2023		$ 243,390,356
Balance, Shares at Jun. 30, 2023		23,000,000
Balance, Shares at Dec. 31, 2022				5,750,000
Balance at Jun. 30, 2023	(8,968,739)			$ 575	(8,969,314)
Balance at Mar. 31, 2023		$ 240,522,631
Balance, Shares at Mar. 31, 2023		23,000,000
Balance at Mar. 31, 2023	(8,667,615)			$ 575	(8,668,190)
Accretion of Class A ordinary shares to redemption value	(2,867,725)	$ 2,867,725			(2,867,725)
Net income (loss)	2,566,601	2,053,281	$ 513,320		2,566,601
Balance at Jun. 30, 2023		$ 243,390,356
Balance, Shares at Jun. 30, 2023		23,000,000
Balance, Shares at Mar. 31, 2023				5,750,000
Balance at Jun. 30, 2023	$ (8,968,739)			$ 575	$ (8,969,314)

Condensed Statement of Cash Flows - USD ($)	6 Months Ended
Condensed Statement of Cash Flows - USD ($)	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ 4,561,715	$ (415,026)
Adjustments to reconcile net loss to net cash used in operating activities:
Realized and unrealized gain on marketable securities held in trust	(1,440,963)	(241,801)
Change in accrued interest included in marketable securities held in trust	(1,007,769)	0
Changes in operating assets and liabilities:
Prepaid expenses	248,210	274,600
Accrued expenses and related party payable	198,160	(30,269)
Net cash provided by (used in) operating activities	2,559,353	(412,496)
Cash flows from investing activities:
Proceeds from redemption of marketable securities held in trust account	239,435,000	234,718,663
Investment in marketable securities held in trust account	(242,382,588)	(234,718,663)
Net cash used in investing activities	(2,947,588)	0
Cash flows from financing activities:
Cash proceeds from working capital loan	258,001	0
Net cash provided by financing activities	258,001	0
Net change in cash and restricted cash	(130,234)	(412,496)
Cash and restricted cash – beginning of period	154,837	416,437
Cash and restricted cash – end of period	24,603	3,941
Supplemental disclosure of non-cash investing and financing activities:
Accretion of Class A ordinary shares to redemption value	$ 5,395,450	$ 241,801

Description of Organization, Business Operations and Basis of Presentation	6 Months Ended
	Jun. 30, 2023
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Description of Organization, Business Operations and Basis of Presentation	Note 1—Description of Organization, Business Operations and Basis of Presentation UTA Acquisition Corporation (the “Company”) was incorporated as a Cayman Island exempted company on July 15, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As further discussed in the Business Combination section, the Company has until September 6, 2023 to complete a Business Combination, at which time it will be obligated to redeem 100% of the public shares if it is unable to do so, as defined and described below. As of June 30, 2023, the Company has not taken any action to extend the business combination period beyond September 6, 2023. As of June 30, 2023, the Company had not commenced any operations. All activity through June 30, 2023 relates to the Company’s formation, the initial public offering (“IPO”) described below, and identifying a target for an initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end. Sponsor and Financing The Company’s sponsor is UTA Acquisition Sponsor, LLC (the “Sponsor”). The registration statement for the Company’s IPO was declared effective on December 1, 2021. On December 6, 2021, the Company consummated its IPO of 23,000,000 units (the “Units”), including the issuance of 3,000,000 Units as a result of the underwriter’s exercise of its over-allotment option. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (an “Ordinary Share”, with each such Ordinary Share included in the Units being offered, the “Public Shares”), and one-half of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Ordinary Share for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000. Substantially concurrently with the closing of the IPO, the Company completed the private sale of 11,200,000 Private Placement Warrants at a purchase price of $1.00 per Private Placement Warrant, to the Sponsor, generating gross proceeds to the Company of $11,200,000 as discussed in Note 4. Transaction costs of the IPO amounted to $13,252,780 consisting of $4,600,000 of underwriting discounts and commissions, $8,050,000 of deferred underwriting discounts and commissions, and $602,780 of other offering costs. Trust Account A total of $234,600,000, comprised of proceeds from the IPO and the sale of the Private Placement Warrants, was placed in the Trust Account, a U.S.-based trust account at JP Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee, and invested only in U.S government treasury bills with a maturity of 185 days or less or in money market funds meeting certain conditions of Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the funds held in the Trust Account will not be released from the Trust Account until the earliest to occur of: (1) the completion of the Company’s initial business combination; (2) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial business combination or to redeem 100% of its public shares if the Company does not complete its initial business combination within 21 months from the closing of the IPO or (B) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity; and (3) the redemption of the Company’s public shares if the Company has not completed its initial business combination within 21 months from the closing of the IPO, subject to applicable law. As of June 30, 2023 and December 31, 2022, marketable securities held in the Trust Account amounted to $243,390,357 and $237,994,037, respectively. Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially all the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes and excluding the amount of any deferred underwriting discount held in trust) at the time of the agreement to enter the initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). The Company will provide holders of the Company’s outstanding Class A ordinary shares sold in the IPO (the “Public Shareholders”), the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account. The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares are classified as temporary equity and subsequentially accreted to redemption value in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will not redeem the Public Shares in an amount that would cause its net tangible assets to be less than $5,000,005. The Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by applicable law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its amended and restated certificate of incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by applicable law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor and the Company’s officers and directors have agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the IPO in favor of a Business Combination. In addition, the Sponsor and the Company’s officers and directors have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. The Certificate of Incorporation provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor and the Company’s officers and directors have agreed not to propose an amendment to the Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemptions in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other material provision relating to shares’ rights or pre-business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. If the Company is unable to complete a Business Combination within 21 months from the closing of the IPO (the “Combination Period”), September 6, 2023, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less amounts released to pay taxes and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, liquidate and dissolve, subject in each case, to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. The holders of the Company’s Founder Shares prior to the IPO (the “initial shareholders”) have agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders or the Company’s officers and directors acquire Public Shares in or after the IPO, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.20. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective targets or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity, Capital Resources and Going Concern As of June 3 0 , 2023, the Company had $24,603 in cash and working capital deficiency of $ 918,740. The working capital calculation excludes amounts held in the Trust Account from current assets and excludes deferred underwriters’ fees from current liabilities. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor agreed to loan the Company an aggregate of up to $2,500,000 funds as may be required (“Working Capital Loans”). As of June 30, 2023, the Company had $835,993 in outstanding borrowings under such Working Capital Loans. The Company uses funds held outside of the Trust Account and borrowings under the Working Capital Loans to pay existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating a Business Combination. The Company believes that the funds available may not be sufficient to meet the expenditures required for operating our business through a period of one year from the date of these condensed financial statements. We may need to obtain additional financing either to complete an initial business combination or because we become obligated to redeem a significant number of our Public Shares upon completion of an initial business combination, in which case we may issue additional securities or incur debt in connection with such business combination. There is no assurance that management would be able to secure these additional funds. As a result, the Company’s management has determined that the current liquidity conditions raise substantial doubt about our ability to continue as a going concern.

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2—Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited

interim

Emerging Growth Company

non-emerging

Use of Estimates

Cash and Cash Equivalents

Restricted Cash Held in Trust Account

Marketable Securities Held in Trust Account

Concentration of Credit Risk

Class A Ordinary Shares Subject to Possible Redemption

paid-in

capital, or in the absence of additional capital, in accumulated deficit. For the three and six months ended June 30, 2023, the Company recorded an-upward accretion to redemption value of $

2,867,725

and $5,395,450

accumulated

deficit.

Offering Costs

June 30, 2023 and 2022,

no offering costs were incurred or recorded.

Net Income (Loss) Per Ordinary Share

With respect to the accretion of Class A ordinary shares subject to possible redemption and consistent with ASC Topic

480-10-S99-3A,

the Company treated accretion in the same manner as a dividend, paid to the shareholder in the calculation of the net income loss per ordinary share.

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):


	For the Three Months Ended June 30,						For the Six Months Ended June 30,
	2023			2022			2023			2022


Net income (loss)	$	2,566,601		$	15,451		$	4,561,715		$	(415,026	)
Accretion of temporary equity to redemption value		(2,867,725	)		(297,906	)		(5,395,450	)		(241,801	)

Net loss including accretion of temporary equity to redemption value		(301,124	)		(282,455	)		(833,735	)		(656,827	)


	For the Three Months Ended June 30, 2023						For the Six Months Ended June 30, 2023
	Class A			Class B			Class A			Class B
Numerator:
Total income (loss) allocated by Class		2,053,281			513,320			3,649,372			912,343
Less: Accretion allocated based on ownership percentage		(2,294,180	)		(573,545	)		(4,316,360	)		(1,079,090	)
Plus: accretion applicable to Class A redeemable Shares		2,867,725						5,395,450

Total income (loss) by Class	$	2,626,826		$	(60,225	)		4,728,462		$	(166,747	)


Denominator :
Weighted average shares		23,000,000			5,750,000			23,000,000			5,750,000
Basic and diluted net income (loss) per ordinary share		0.11			(0.01	)		0.21			(0.03	)


	For the Three Months Ended June 30, 2022						For the Six Months Ended June 30, 2022
	Class A			Class B			Class A			Class B
Numerator:
Total income (loss) allocated by Class		12,361			3,090			(332,021	)		(83,005	)
Less: Accretion allocated based on ownership percentage		(238,325	)		(59,581	)		(193,441	)		(48,360	)
Plus: accretion applicable to Class A redeemable Shares		297,906			—			241,801			—

Total income (loss) by Class	$	71,942		$	(56,491	)		(283,661	)	$	(131,365	)

Denominator :
Weighted average shares		23,000,000			5,750,000			23,000,000			5,750,000
Basic and diluted net income (loss) per ordinary share		0.00			(0.01	)		(0.01	)		(0.02	)

Income Taxes

Financial Instruments

Fair Value Measurement

ASC 820 establishes a fair value hierarchy that prioritizes and ranks the level of observability of inputs used to measure investments at fair value.

The three levels of the fair value hierarchy under ASC 820 are as follows:

Level 1—Quoted prices (unadjusted) in active markets for identical investments at the measurement date are used.

Recent Accounting Pronouncements

The Company’s management does not believe that any recently issued accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements.

Initial Public Offering	6 Months Ended
Initial Public Offering	Jun. 30, 2023
Initial Public Offering [Abstract]
Initial Public Offering	Note 3—Initial Public Offering As discussed in Note 1, on December 6, 2021, the Company consummated its IPO of 23,000,000 Units, including the issuance of 3,000,000 Units as a result of the underwriter’s exercise of its over-allotment option. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000. Substantially concurrently with the closing of the IPO, the Company completed the private sale of 11,200,000 Private Placement Warrants at a purchase price of $1.00 per Private Placement Warrant, to the Sponsor, generating gross proceeds to the Company of $11,200,000.

Related Party Transactions	6 Months Ended
Related Party Transactions	Jun. 30, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Note 4—Related Party Transactions Founder Shares On July 22, 2021, the Sponsor paid an aggregate price of $25,000 to cover certain expenses on behalf of the Company in exchange for an initial issuance of 7,187,500 shares of Class B ordinary shares (the “Founder Shares”). In November 2021, the Sponsor surrendered an aggregate of 1,437,500 Founder Shares for no consideration, resulting in an aggregate of 5,750,000 Class B ordinary shares outstanding. All share and per share amounts have been retroactively restated to reflect the share surrender. In November 2021, the Sponsor transferred 25,000 Founder Shares each to Nancy Tellem and Alexis Ohanian, the Company’s independent director nominees. The initial shareholders, including the Sponsor, have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (i) one year after the completion of the initial Business Combination and (ii) subsequent to our initial business combination (x) if the last reported sale price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, consolidations, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30 -trading day period commencing at least 150 days after our initial business combination or (y) the date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Private Placement Warrants Substantially concurrently with the closing of the IPO, the Company completed the private sale of 11,200,000 Private Placement Warrants at a purchase price of $1.00 per Private Placement Warrant, to the Sponsor, generating gross proceeds to the Company of $11,200,000. Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable for cash and exercisable for cash or on a cashless basis so long as they are held by the Sponsor or its permitted transferees. The Sponsor and the Company’s officers and directors have agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. The Private Placement Warrants are identical to the warrants sold as part of the Units in the IPO except that, so long as they are held by the Sponsor or its permitted transferees: (1) they will not be redeemable by the Company (except in certain redemption scenarios when the price per Class A ordinary share equals or exceeds $10.00 (as adjusted)); (2) they (including the Class A ordinary shares issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the Company’s initial business combination; (3) they may be exercised by the holders on a cashless basis; and (4) they (including the Ordinary Shares issuable upon exercise of these warrants) are entitled to registration rights. Working Capital Loans—Related Party In order to finance transaction costs in connection with a Business Combination, the Sponsor agreed to loan the Company an aggregate of up to $2,500,000 funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans are non-interest bearing and due at the earlier of (i) September 6, 2023, (ii) the date of consummation of a Business Combination or, (iii) pursuant to acceleration of the obligations upon an event of default. At the lender’s discretion, up to $2,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. The embedded feature to settle the Working Capital Loans upon the occurrence of an event of default is clearly and closely related to the debt host and is therefore not required to be separated. As of June 30, 2023 and December 31, 2022, the Company had $835,993 and $577,992, respectively, in outstanding borrowings under the Working Capital Loans. Administrative Services Agreement On December 1, 2021, the Company entered into an agreement that provides that, commencing on the closing of the IPO and continuing until the earlier of the Company’s consummation of a Business Combination or the Company’s liquidation, the Company will pay an affiliate of the Sponsor a total of $10,000 per month for office space, secretarial and administrative services. The Sponsor subsequently agreed to waive any fees that would have been payable by the Company under the agreement for the month of December 2021. For the three and six months ended June 30, 2023 and 2022, $30,000 and $60,000 respectively, was incurred and recognized in formation and operating costs in the condensed statement of operations. As of June 30, 2023 and December 31, 2022, $ 180,000 and $120,000, respectively, was payable and included in payable to affiliate on the condensed balance sheet. The Sponsor, executive officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made to the Sponsor, officers, directors or their affiliates. No such expenditures were incurred for the three and six months ended June 30, 2023 and 2022.

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Jun. 30, 2023
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 5—Commitments and Contingencies Registration Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement signed upon consummation of the IPO. These holders are entitled to certain demand and “piggyback” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Risks and Uncertainties Management continues to evaluate the impact of the Russia-Ukraine war on the industry and has concluded that while it is reasonably possible that such could have negative effects on the Company’s financial position, results of its operations, and/or search for a target company, the specific impacts are not readily determinable as of the date of these condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of these uncertainties. Underwriting Agreement The underwriters were entitled to an underwriting discount of $0.20 per unit, or $4,600,000 in the aggregate paid upon the closing of the IPO. Additionally, the underwriters are entitled to a deferred underwriting discount of $0.35 per unit, or $8,050,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Class A Ordinary Shares Subject to Possible Redemption

6 Months Ended

Jun. 30, 2023

Temporary Equity Disclosure [Abstract]

Class A Ordinary Shares Subject To Possible Redemption

Note 6—Class A Ordinary Shares Subject to Possible Redemption

As of June 30, 2023, Class A ordinary shares reflected on the balance sheet is reconciled as follows:



Class A ordinary shares subject to possible redemption - December 31, 2022	$	237,994,906
Plus:
Accretion of carrying value to redemption value		5,395,450

Class A ordinary shares subject to possible redemption - June 30, 2023	$	243,390,356

As of June 30, 2022, Class A ordinary shares reflected on the balance sheet is reconciled as follows:



Class A ordinary shares subject to possible redemption - December 31, 2021	$	234,606,064
Plus:
Accretion of carrying value to redemption value		241,801

Class A ordinary shares subject to possible redemption - June 30, 2022	$	234,847,865

Shareholder's Equity

6 Months Ended

Jun. 30, 2023

Equity [Abstract]

Shareholder's Equity

Note 7—Shareholder’s Equity

Preference Shares —

Class

A Ordinary Shares

Class

B Ordinary Shares

The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination, or earlier at the option of the holder, on a

one-for-one

as-converted

one-for-one

basis.

Warrants

— As of June 30, 2023 and December 31, 2022, the Company had 11,500,000 and 11,200,000 Public Warrants and Private Placement Warrants outstanding, respectively.

The Company accounts for both the Public and Private Warrants

in accordance with the guidance contained in ASC

815-40.

Such guidance provides that because the warrants meet the criteria for equity treatment thereunder, each warrant must be recorded within equity.

Once the warrants become exercisable, the Company may redeem the Public Warrants:

•

in whole and not in part;

•

at a price of $0.01 per warrant;

•

at any time after the warrants become exercisable;

•

upon a not less than 30 days’ prior written notice of redemption;

•

if, and only if, the last sales price of the Class A ordinary shares for any 20 days within a

30-trading

day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders equals or exceeds $18.00 per share.

•

if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire

30-day

trading period referred to above and continuing each day thereafter until the date of redemption, or the Company has elected to require the exercise of the Public Warrants on a cashless basis.

The Private Placement Warrants are identical to the warrants sold as part of the Units in the IPO except that, so long as they are held by the Sponsor or its permitted transferees: (1) they will not be redeemable by the Company (except in certain redemption scenarios when the price per Ordinary Share equals or exceeds $10.00 (as adjusted)); (2) they (including the Ordinary Shares issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the Company’s initial business combination; (3) they may be exercised by the holders on a cashless basis; and (4) they (including the Ordinary Shares issuable upon exercise of these warrants) are entitled to registration rights.

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 8—Subsequent Events The Company has evaluated subsequent events and transactions that occurred after the balance sheet date through the date these financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Basis of Presentation

The accompanying unaudited

interim

Emerging Growth Company

non-emerging

Use of Estimates

Cash and Cash Equivalents

Restricted Cash Held in Trust Account

Marketable Securities Held in Trust Account

Concentration of Credit Risk

Class A Ordinary Shares Subject to Possible Redemption

paid-in

capital, or in the absence of additional capital, in accumulated deficit. For the three and six months ended June 30, 2023, the Company recorded an-upward accretion to redemption value of $

2,867,725

and $5,395,450

accumulated

deficit.

Offering Costs

June 30, 2023 and 2022,

no offering costs were incurred or recorded.

Net Income (Loss) Per Ordinary Share

With respect to the accretion of Class A ordinary shares subject to possible redemption and consistent with ASC Topic

480-10-S99-3A,

the Company treated accretion in the same manner as a dividend, paid to the shareholder in the calculation of the net income loss per ordinary share.

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):


	For the Three Months Ended June 30,						For the Six Months Ended June 30,
	2023			2022			2023			2022


Net income (loss)	$	2,566,601		$	15,451		$	4,561,715		$	(415,026	)
Accretion of temporary equity to redemption value		(2,867,725	)		(297,906	)		(5,395,450	)		(241,801	)

Net loss including accretion of temporary equity to redemption value		(301,124	)		(282,455	)		(833,735	)		(656,827	)


	For the Three Months Ended June 30, 2023						For the Six Months Ended June 30, 2023
	Class A			Class B			Class A			Class B
Numerator:
Total income (loss) allocated by Class		2,053,281			513,320			3,649,372			912,343
Less: Accretion allocated based on ownership percentage		(2,294,180	)		(573,545	)		(4,316,360	)		(1,079,090	)
Plus: accretion applicable to Class A redeemable Shares		2,867,725						5,395,450

Total income (loss) by Class	$	2,626,826		$	(60,225	)		4,728,462		$	(166,747	)


Denominator :
Weighted average shares		23,000,000			5,750,000			23,000,000			5,750,000
Basic and diluted net income (loss) per ordinary share		0.11			(0.01	)		0.21			(0.03	)


	For the Three Months Ended June 30, 2022						For the Six Months Ended June 30, 2022
	Class A			Class B			Class A			Class B
Numerator:
Total income (loss) allocated by Class		12,361			3,090			(332,021	)		(83,005	)
Less: Accretion allocated based on ownership percentage		(238,325	)		(59,581	)		(193,441	)		(48,360	)
Plus: accretion applicable to Class A redeemable Shares		297,906			—			241,801			—

Total income (loss) by Class	$	71,942		$	(56,491	)		(283,661	)	$	(131,365	)

Denominator :
Weighted average shares		23,000,000			5,750,000			23,000,000			5,750,000
Basic and diluted net income (loss) per ordinary share		0.00			(0.01	)		(0.01	)		(0.02	)

Income Taxes

Financial Instruments

Fair Value Measurement

ASC 820 establishes a fair value hierarchy that prioritizes and ranks the level of observability of inputs used to measure investments at fair value.

The three levels of the fair value hierarchy under ASC 820 are as follows:

Level 1—Quoted prices (unadjusted) in active markets for identical investments at the measurement date are used.

Recent Accounting Pronouncements

The Company’s management does not believe that any recently issued accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements.

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Summary of Calculation of Basic and Diluted Net Income (Loss) Per Ordinary Share

The following tables reflect the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):


	For the Three Months Ended June 30,						For the Six Months Ended June 30,
	2023			2022			2023			2022


Net income (loss)	$	2,566,601		$	15,451		$	4,561,715		$	(415,026	)
Accretion of temporary equity to redemption value		(2,867,725	)		(297,906	)		(5,395,450	)		(241,801	)

Net loss including accretion of temporary equity to redemption value		(301,124	)		(282,455	)		(833,735	)		(656,827	)


	For the Three Months Ended June 30, 2023						For the Six Months Ended June 30, 2023
	Class A			Class B			Class A			Class B
Numerator:
Total income (loss) allocated by Class		2,053,281			513,320			3,649,372			912,343
Less: Accretion allocated based on ownership percentage		(2,294,180	)		(573,545	)		(4,316,360	)		(1,079,090	)
Plus: accretion applicable to Class A redeemable Shares		2,867,725						5,395,450

Total income (loss) by Class	$	2,626,826		$	(60,225	)		4,728,462		$	(166,747	)


Denominator :
Weighted average shares		23,000,000			5,750,000			23,000,000			5,750,000
Basic and diluted net income (loss) per ordinary share		0.11			(0.01	)		0.21			(0.03	)


	For the Three Months Ended June 30, 2022						For the Six Months Ended June 30, 2022
	Class A			Class B			Class A			Class B
Numerator:
Total income (loss) allocated by Class		12,361			3,090			(332,021	)		(83,005	)
Less: Accretion allocated based on ownership percentage		(238,325	)		(59,581	)		(193,441	)		(48,360	)
Plus: accretion applicable to Class A redeemable Shares		297,906			—			241,801			—

Total income (loss) by Class	$	71,942		$	(56,491	)		(283,661	)	$	(131,365	)

Denominator :
Weighted average shares		23,000,000			5,750,000			23,000,000			5,750,000
Basic and diluted net income (loss) per ordinary share		0.00			(0.01	)		(0.01	)		(0.02	)

Class A Ordinary Shares Subject to Possible Redemption (Tables)

6 Months Ended

Jun. 30, 2023

Temporary Equity Disclosure [Abstract]

Summary of Reconciliation of Class A Ordinary Shares Reflected on Balance Sheet

As of June 30, 2023, Class A ordinary shares reflected on the balance sheet is reconciled as follows:



Class A ordinary shares subject to possible redemption - December 31, 2022	$	237,994,906
Plus:
Accretion of carrying value to redemption value		5,395,450

Class A ordinary shares subject to possible redemption - June 30, 2023	$	243,390,356

As of June 30, 2022, Class A ordinary shares reflected on the balance sheet is reconciled as follows:



Class A ordinary shares subject to possible redemption - December 31, 2021	$	234,606,064
Plus:
Accretion of carrying value to redemption value		241,801

Class A ordinary shares subject to possible redemption - June 30, 2022	$	234,847,865

Description of Organization, Business Operations and Basis of Presentation - Additional Information (Details) - USD ($)		6 Months Ended
	Dec. 06, 2021	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022	Dec. 31, 2021	Jul. 22, 2021
Class Of Stock [Line Items]
Entity incorporation, date of incorporation		Jul. 15, 2021
Units issued price per share		$ 10
Marketable securities held in Trust Account			$ 237,994,037
Trust account release terms		the funds held in the Trust Account will not be released from the Trust Account until the earliest to occur of: (1) the completion of the Company’s initial business combination; (2) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial business combination or to redeem 100% of its public shares if the Company does not complete its initial business combination within 21 months from the closing of the IPO or (B) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity; and (3) the redemption of the Company’s public shares if the Company has not completed its initial business combination within 21 months from the closing of the IPO, subject to applicable law.
Marketable securities held in Trust Account		$ 243,390,357	237,994,037
Minimum percentage of initial business combination fair market value of net assets held in trust account		80.00%
Minimum percentage of ownership required to complete business combination		50.00%
Maximum net tangible assets redeem amount		$ 5,000,005
Minimum redeeming percentage of public shares		15.00%
Business combination incomplete redeem percentage of public shares		100.00%
Business combination complete period		21 months
Business combination incomplete, maximum period of redeem public shares		10 days
Business combination incomplete, maximum interest to pay dissolution expenses		$ 100,000
Business combination incomplete, redemption rights or liquidating distributions respect to warrants amount		$ 0
Residual assets value per share remaining available for distribution		$ 10.2
Business combination agreement, reduce amount of funds in trust account, description		Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets
Cash		$ 24,603	154,837	$ 3,941	$ 416,437
Working capital amount		918,740
Borrowings		$ 835,993
Maximum
Class Of Stock [Line Items]
Units issued price per share		$ 10
Working Capital Loans \| Maximum
Class Of Stock [Line Items]
Loan to the company		$ 2,500,000				$ 2,500,000
Warrant \| Working Capital Loans
Class Of Stock [Line Items]
Sale of warrants price per warrant						$ 1
Borrowings		835,993	$ 577,992
Initial Public Offering
Class Of Stock [Line Items]
Issuance of shares, Shares	23,000,000
Gross proceeds from issuance of initial public offering	$ 230,000,000
Sponsor \| Private Placement Warrants
Class Of Stock [Line Items]
Sale of warrants	11,200,000
Sale of warrants price per warrant	$ 1
Gross proceeds from private placements warrants	$ 11,200,000
Sponsor \| Initial Public Offering
Class Of Stock [Line Items]
Issuance of shares, Shares	23,000,000
Sale of Stock, Description of Transaction	Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (an “Ordinary Share”, with each such Ordinary Share included in the Units being offered, the “Public Shares”), and one-half of one redeemable warrant of the Company.
Units issued price per share	$ 10
Gross proceeds from issuance of initial public offering	$ 230,000,000
Initial public offering cost	13,252,780
Underwriting discounts and commissions	4,600,000
Deferred underwriting discounts and commissions	8,050,000
Other offering cost	$ 602,780
Sponsor \| Over-Allotment Option
Class Of Stock [Line Items]
Units issued during period	3,000,000
Trust Account
Class Of Stock [Line Items]
Marketable securities held in Trust Account		$ 234,600,000
Class A Ordinary Shares
Class Of Stock [Line Items]
Common stock, par value		$ 0.0001	$ 0.0001
Class A Ordinary Shares \| Sponsor
Class Of Stock [Line Items]
Number of securities called by each warrant	1
Units issued price per share	$ 11.5
Class A Ordinary Shares \| Sponsor \| Initial Public Offering
Class Of Stock [Line Items]
Common stock, par value	$ 0.0001
Number of securities called by each warrant	1
Units issued price per share	$ 11.5

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)		3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 06, 2021	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2021
Summary Of Significant Accounting Policies [Line Items]
Cash equivalents		$ 0		$ 0		$ 0
Restricted cash held in Trust Account		0		0		869
Federal Depository Insurance Coverage limit		250,000		250,000
Unrecognized tax benefits		0		0		0
Accrued interest and penalties related to unrecognized tax benefits		0		0		0
Tax provision				0		$ 0
Initial Public Offering
Summary Of Significant Accounting Policies [Line Items]
Offering Costs	$ 13,252,780	$ 0	$ 0	$ 0	$ 0
Initial Public Offering \| Public Warrants
Summary Of Significant Accounting Policies [Line Items]
Offering Costs	529,582
Class A Ordinary Shares Subject to Possible Redemption
Summary Of Significant Accounting Policies [Line Items]
Class A ordinary shares subject to possible redemption at redemption shares outstanding		23,000,000	23,000,000	23,000,000	23,000,000	23,000,000	23,000,000	23,000,000	23,000,000
Class A Ordinary Shares \| Initial Public Offering
Summary Of Significant Accounting Policies [Line Items]
Offering Costs	$ 12,723,198
Accumulated Deficit
Summary Of Significant Accounting Policies [Line Items]
Adjustments for Accretion of Class A ordinary shares to redemption value		$ 2,867,725	$ 297,906	$ 5,395,450	$ 241,801
Maximum
Summary Of Significant Accounting Policies [Line Items]
Investments held in trust account maturity period				185 days		185 days

Summary of Significant Accounting Policies - Summary of Calculation of Basic and Diluted Net Income (Loss) Per Ordinary Share (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
Numerator:
Net income (loss)	$ 2,566,601	$ 1,995,114	$ 15,451	$ (430,477)	$ 4,561,715	$ (415,026)
Accretion of temporary equity to redemption value	(2,867,725)		(297,906)		(5,395,450)	(241,801)
Net loss including accretion of temporary equity to redemption value	(301,124)		(282,455)		(833,735)	(656,827)
Class A Ordinary Shares Subject to Possible Redemption
Numerator:
Net income (loss)	2,053,281		12,361		3,649,372	(332,021)
Less: Accretion allocated based on ownership percentage	(2,294,180)		(238,325)		(4,316,360)	(193,441)
Accretion of temporary equity to redemption value	2,867,725		297,906		5,395,450	241,801
Net loss including accretion of temporary equity to redemption value	$ 2,626,826		$ 71,942		$ 4,728,462	$ (283,661)
Denominator
Weighted average shares outstanding of class A and B ordinary shares subject to possible redemption, basic	23,000,000		23,000,000		23,000,000	23,000,000
Weighted average shares outstanding of class A and B ordinary shares subject to possible redemption, diluted	23,000,000		23,000,000		23,000,000	23,000,000
Basic net income (loss) per share, Class A and B ordinary shares subject to possible redemption	$ 0.11		$ 0		$ 0.21	$ (0.01)
Diluted net income (loss) per share, Class A and B ordinary shares subject to possible redemption	$ 0.11		$ 0		$ 0.21	$ (0.01)
Class B Ordinary Shares
Numerator:
Net income (loss)	$ 513,320		$ 3,090		$ 912,343	$ (83,005)
Less: Accretion allocated based on ownership percentage	(573,545)		(59,581)		(1,079,090)	(48,360)
Accretion of temporary equity to redemption value			0			0
Net loss including accretion of temporary equity to redemption value	$ (60,225)		$ (56,491)		$ (166,747)	$ (131,365)
Denominator
Weighted average shares outstanding of class A and B ordinary shares subject to possible redemption, basic	5,750,000		5,750,000		5,750,000	5,750,000
Weighted average shares outstanding of class A and B ordinary shares subject to possible redemption, diluted	5,750,000		5,750,000		5,750,000	5,750,000
Basic net income (loss) per share, Class A and B ordinary shares subject to possible redemption	$ (0.01)		$ (0.01)		$ (0.03)	$ (0.02)
Diluted net income (loss) per share, Class A and B ordinary shares subject to possible redemption	$ (0.01)		$ (0.01)		$ (0.03)	$ (0.02)

Initial Public Offering - Additional Information (Details)	Dec. 06, 2021 USD ($) $ / shares shares
Initial Public Offering
Initial Public Offering [Line Items]
Issuance of shares, Shares	23,000,000
Share price, per share \| $ / shares	$ 10
Gross proceeds from issuance of initial public offering \| $	$ 230,000,000
Over-Allotment Option
Initial Public Offering [Line Items]
Common stock, shares issued	3,000,000
Sponsor \| Initial Public Offering
Initial Public Offering [Line Items]
Issuance of shares, Shares	23,000,000
Gross proceeds from issuance of initial public offering \| $	$ 230,000,000
Warrant \| Sponsor \| Private Placement
Initial Public Offering [Line Items]
Gross proceeds from issuance of initial public offering \| $	$ 11,200,000
Sale of warrants	11,200,000
Sale of warrants price per warrant \| $ / shares	$ 1

Related Party Transactions - Additional Information (Details) - USD ($)				1 Months Ended	3 Months Ended	6 Months Ended
	Dec. 06, 2021	Dec. 01, 2021	Jul. 22, 2021	Nov. 30, 2021	Jun. 30, 2022	Jun. 30, 2022	Jun. 30, 2023	Dec. 31, 2022
Related Party Transaction [Line Items]
Common stock issued, price per share							$ 10
Common stock threshold consecutive trading days			30 days
Borrowings							$ 835,993
Related Party Transaction, Expenses from Transactions with Related Party					$ 30,000	$ 60,000
Due to Affiliate, Current							$ 180,000	$ 120,000
Administrative Services Agreement
Related Party Transaction [Line Items]
Monthly payment to affiliate of sponsor for office space, secretarial and administrative services		$ 10,000
Maximum
Related Party Transaction [Line Items]
Common stock issued, price per share							$ 10
Maximum \| Working Capital Loans
Related Party Transaction [Line Items]
Loan to the company			$ 2,500,000				$ 2,500,000
Class B Ordinary Shares
Related Party Transaction [Line Items]
Common stock, shares outstanding							5,750,000	5,750,000
Class A Ordinary Shares
Related Party Transaction [Line Items]
Common stock, shares outstanding							0	0
Sponsor \| Class A Ordinary Shares
Related Party Transaction [Line Items]
Common stock issued, price per share	$ 11.5
Number of securities called by each warrant	1
Founder Shares \| Class B Ordinary Shares
Related Party Transaction [Line Items]
Common stock, shares outstanding				5,750,000
Founder Shares \| Sponsor
Related Party Transaction [Line Items]
Shares transferred				25,000
Threshold period after completion of initial business combination			1 year
Common stock threshold trading days			20 days
Minimum holding period for shares after business combination			150 days
Founder Shares \| Sponsor \| Class B Ordinary Shares
Related Party Transaction [Line Items]
Issuance of Class B ordinary shares to Sponsor			$ 25,000
Units issued during period			7,187,500
Ordinary shares surrendered				1,437,500
Ordinary shares surrendered, consideration amount				$ 0
Founder Shares \| Sponsor \| Class A Ordinary Shares \| Maximum
Related Party Transaction [Line Items]
Common stock issued, price per share			$ 12
Warrant \| Working Capital Loans
Related Party Transaction [Line Items]
Sale of warrants price per warrant			$ 1
Borrowings							$ 835,993	$ 577,992
Warrant \| Private Placement
Related Party Transaction [Line Items]
Warrants holding period after completion of business combination	30 days
Warrant \| Maximum \| Working Capital Loans
Related Party Transaction [Line Items]
Debt conversion converted instrument amount			$ 2,500,000
Warrant \| Sponsor \| Private Placement
Related Party Transaction [Line Items]
Common stock issued, price per share	$ 10
Sale of warrants	11,200,000
Sale of warrants price per warrant	$ 1
Gross proceeds from issuance of initial public offering	$ 11,200,000

Commitments and Contingencies - Additional Information (Details)	Jun. 30, 2023 $ / shares shares
Commitments And Contingencies Disclosure [Abstract]
Underwriting discount price per share \| $ / shares	$ 0.2
Underwriting discount aggregate number of shares entitled \| shares	4,600,000
Deferred underwriting discount price per share \| $ / shares	$ 0.35
Deferred underwriting discount aggregate number of shares entitled \| shares	8,050,000

Class A Ordinary Shares Subject to Possible Redemption - Additional Information (Details) - Class A Ordinary Shares Subject to Possible Redemption - $ / shares	6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Temporary Equity [Line Items]
Temporary equity, shares authorized	80,000,000
Temporary equity, par value	$ 0.0001
Temporary equity voting rights	one vote
Class A ordinary shares subject to possible redemption at redemption shares outstanding	23,000,000	23,000,000	23,000,000	23,000,000	23,000,000	23,000,000

Class A Ordinary Shares Subject to Possible Redemption - Summary of Reconciliation of Class A Ordinary Shares Reflected on Balance Sheet (Details) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Temporary Equity [Line Items]
Accretion of carrying value to redemption value	$ 5,395,450	$ 241,801
Class A Ordinary Shares Subject to Possible Redemption
Temporary Equity [Line Items]
Balance	237,994,906	234,606,064
Accretion of carrying value to redemption value	5,395,450	241,801
Balance	$ 243,390,356	$ 234,847,865

Shareholder's Equity - Additional Information (Details) - USD ($)	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Class Of Stock [Line Items]
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, voting rights	one
Common stock, conversion basis	one-for-one basis
Percentage of common stock shares outstanding	20.00%
Percentage of equity proceeds	60.00%
Price of newly issued stock to cause adjustment of exercise warrant price	$ 9.2
Percentage of warrant exercise price adjusted to price received in new issuance	115.00%
Common stock issued, price per share	$ 10
Class A Ordinary Shares
Class Of Stock [Line Items]
Common stock, shares authorized	80,000,000	80,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock shares issued subject to redemption	23,000,000	23,000,000
Common stock shares outstanding subject to redemption	23,000,000	23,000,000
Common stock, shares outstanding	0	0
Class B Ordinary Shares
Class Of Stock [Line Items]
Common stock, shares authorized	20,000,000	20,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares outstanding	5,750,000	5,750,000
Class B Ordinary Shares \| Sponsor
Class Of Stock [Line Items]
Issuance of Class B ordinary shares to Sponsor	$ 25,000
Public Warrants
Class Of Stock [Line Items]
Class of warrants or rights outstanding	11,500,000	11,500,000
Class of warrants or rights, days from which warrants are exercisable	30 days
Class of warrants or rights, months from which warrants are exercisable	12 months
Class of warrants or rights, outstanding term	5 years
Class of warrant or right redemption price	$ 0.01
Prior written notice period of warrants for redemption	30 days
Public Warrants \| Class A Ordinary Shares
Class Of Stock [Line Items]
Number of trading days for determining the share price	20 days
Common stock redemption stock price per share	$ 18
Private Placement Warrants
Class Of Stock [Line Items]
Class of warrants or rights outstanding	11,200,000	11,200,000
Maximum
Class Of Stock [Line Items]
Common stock issued, price per share	$ 10
Maximum \| Class A Ordinary Shares
Class Of Stock [Line Items]
Initial business combination effective issue price per share	$ 9.2